Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Joana Tomás"'
Publikováno v:
Future Internet, Vol 14, Iss 6, p 167 (2022)
In recent years, the use of personal data in marketing, scientific and medical investigation, and forecasting future trends has really increased. This information is used by the government, companies, and individuals, and should not contain any sensi
Externí odkaz:
https://doaj.org/article/cd5e8e1a68bd473e975f1dd1b66c24a6
Autor:
Patrícia Pereira, Maria Barreira, Carla Cruz, Joana Tomás, Ângelo Luís, Augusto Q. Pedro, João A. Queiroz, Fani Sousa
Publikováno v:
Pharmaceuticals, Vol 13, Iss 10, p 314 (2020)
The efficacy of brain therapeutics is largely hampered by the presence of the blood–brain barrier (BBB), mainly due to the failure of most (bio) pharmaceuticals to cross it. Accordingly, this study aims to develop nanocarriers for targeted delivery
Externí odkaz:
https://doaj.org/article/50ad08d9ee8c4e568831249a19d12463
Publikováno v:
Conservar Património; set2024, Vol. 47, p12-27, 16p
Autor:
FERREIRA, JOANA TOMÁS, DER DE VRIEZE, SAN, VAN DER VELDE, ELINE, VERKENS, KIM, DE SÁ, SUSANA FRANÇA
Publikováno v:
Conservar Património; set2024, Vol. 47, p43-59, 17p
Autor:
DE SÁ, SUSANA FRANÇA, FERREIRA, JOANA TOMÁS, CARITA, MADALENA, CORREIA, INÊS, VAN DER VELDE, ELINE, VERKENS, KIM
Publikováno v:
Conservar Património; set2024, Vol. 47, p28-42, 15p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mónica Oleastro, Fernanda C. Domingues, Cristiana Mateus, Joana Tomás, Susana Ferreira, Ana L Silva
Publikováno v:
Antimicrob Agents Chemother
Aliarcobacter butzleri is an emergent enteropathogen for which resistance to several classes of antimicrobial agents has been described, although the underlying mechanisms have been poorly addressed. We aimed to evaluate the contribution of the resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66bc707d6a9ab98e4bbd050771589d50
https://doi.org/10.1128/aac.00729-21
https://doi.org/10.1128/aac.00729-21
Autor:
Ana Catarina Duarte, Cecília R.A. Santos, Isabel Gonçalves, Joana Tomás, Telma Quintela, Ana R. Costa-Brito, Daniela Talhada, Ana R. Costa
Publikováno v:
Journal of Neuroscience Research. 98:751-753
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98407ce51d37faffce0f618d875833dd
https://doi.org/10.1002/jnr.24571
https://doi.org/10.1002/jnr.24571
Adenosine inhibits cell proliferation differently in human astrocytes and in glioblastoma cell lines
Autor:
Cecília R.A. Santos, Bruno M. Costa, José F. Cascalheira, Ana C. Honório, Helena Marcelino, Ana M. Sebastião, Tiago M.A. Carvalho, Joana Tomás, Ana R. Costa, Francisca I. Teles, Carolina B. Rosa
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
© 2021 IBRO. Published by Elsevier Ltd. All rights reserved.
Glioblastoma (GBM) is the most common brain primary tumour. Hypoxic regions in GBM are associated to tumour growth. Adenosine accumulates in hypoxic regions and can affect cell prolif
Glioblastoma (GBM) is the most common brain primary tumour. Hypoxic regions in GBM are associated to tumour growth. Adenosine accumulates in hypoxic regions and can affect cell prolif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::397dbb687a09328a9e87e336739d2dd3
https://hdl.handle.net/10451/48995
https://hdl.handle.net/10451/48995
Autor:
Joana Tomás, Maria Barreira, João A. Queiroz, Carla Cruz, Augusto Q. Pedro, Patricia N R Pereira, Fani Sousa, Ângelo Luís
Publikováno v:
Pharmaceuticals
Volume 13
Issue 10
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Pharmaceuticals, Vol 13, Iss 314, p 314 (2020)
Volume 13
Issue 10
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Pharmaceuticals, Vol 13, Iss 314, p 314 (2020)
The efficacy of brain therapeutics is largely hampered by the presence of the blood&ndash
brain barrier (BBB), mainly due to the failure of most (bio) pharmaceuticals to cross it. Accordingly, this study aims to develop nanocarriers for targeted
brain barrier (BBB), mainly due to the failure of most (bio) pharmaceuticals to cross it. Accordingly, this study aims to develop nanocarriers for targeted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b293d6db132bcfdf9973b91bf4c85187